Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC-L in Advanced Colorectal Cancer
NCT06446050Phase 1Recruiting
- Sponsor
- Shanghai East Hospital
- Start
- Jun 2023
- Primary completion
- Dec 2026
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Provacel in colorectal cancer (CRC), sponsored by Shanghai East Hospital. Primary endpoints: Dose-Limiting Toxicities rate at 4 months, Adverse Event at 4 months and 1 more. Started Jun 2023; status: recruiting.
02
Drugs
Provacel
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06446050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06446050.